In > 80% of Barrett's oesophagus (BE) and EAC samples, TGF‐β signalling is impaired, and genomic alterations in the members of the superfamily of TGF‐β pathway components occur in 65% of EAC. This evidence concerns the gene TGFB1 and Barrett esophagus.